Scinai Immunotherapeutics Ltd. SCNI Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001213900-25-040402
cik 1611747
name SCINAI IMMUNOTHERAPEUTICS LTD.
sic 2836
countryba IL
stprba
cityba JERUSALEM
zipba 00000
bas1 JERUSALEM BIOPARK, 2ND FLOOR
bas2 HADASSAH EIN KEREM CAMPUS
baph 972-8-9302529
countryma IL
stprma
cityma JERUSALEM
zipma 00000
mas1 JERUSALEM BIOPARK, 2ND FLOOR
mas2 HADASSAH EIN KEREM CAMPUS
countryinc IL
stprinc
ein 000000000
former BIONDVAX PHARMACEUTICALS LTD.
changed 20140624
afs 4-NON
wksi 0
fye 1231
form 20-F
period 20241231
fy 2024
fp FY
filed 20250507
accepted 2025-05-07 07:42:00.0
prevrpt 0
detail 1
instance ea0239669-20f_scinai_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001213900-25-040402 20241231 Stock Issued During Period Value Issuance Of Prefunded Shares 2000000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Warrant Issued 1086000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -9205000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Common Stock No Par Value USD 0 us-gaap/2024
0001213900-25-040402 20231231 Common Stock Shares Authorized 20000000000.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Comprehensive Income Net Of Tax 4796000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Cost Of Revenue 1238000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Earnings Per Share Diluted 0.0040 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Exercise Of Warrants Liability Into Shares USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Increase Decrease In Accounts Payable Trade -175000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Accounts Receivable USD 4 us-gaap/2024
0001213900-25-040402 20221231 Increase Decrease In Other Accounts Payable 309000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Other Accounts Payable -341000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Other Operating Assets -43000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Increase Decrease In Other Operating Assets -284000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Liabilities Noncurrent 1665000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Net Cash Provided By Used In Financing Activities 1086000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Net Cash Provided By Used In Investing Activities -836000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Net Cash Provided By Used In Operating Activities -6335000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Net Income Loss -6500000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20241231 Operating Lease Right Of Use Asset 1868000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 4 us-gaap/2024
0001213900-25-040402 20221231 Other Comprehensive Income Loss Net Of Tax 48000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Other Nonoperating Income USD 4 us-gaap/2024
0001213900-25-040402 20241231 Proceeds From Issuance Of Common Stock 2000000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Proceeds From Warrant Exercises 947000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Reclassifications Of Temporary To Permanent Equity USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20231231 Restricted Cash 140000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Stockholders Equity 9977000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Stock Issued During Period Shares Exercise Of Prefunded Warrant 448620800.0000 shares 4 0001213900-25-040402 Equity Components= Common Stock;
0001213900-25-040402 20241231 Stock Issued During Period Shares Restricted Stock Award Gross shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Shares Stock Options Exercised 584015200.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20221231 Stock Issued During Period Value New Issues 1154000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Stock Options Exercised 801000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Stock Issued During Period Value Stock Options Exercised 801000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Assets Current 5447000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Common Stock Shares Issued 1857169984.0000 shares 0 us-gaap/2024
0001213900-25-040402 20231231 Common Stock Shares Outstanding 1857169984.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Common Stock Shares Outstanding 3411983584.0000 shares 0 us-gaap/2024
0001213900-25-040402 20231231 Common Stock Value USD 0 us-gaap/2024
0001213900-25-040402 20241231 Common Stock Value USD 0 us-gaap/2024
0001213900-25-040402 20231231 Comprehensive Income Net Of Tax -6233000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Deferred Finance Costs Net 263000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Earnings Per Share Basic 0.0040 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -1977000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Gains Losses On Restructuring Of Debt USD 4 us-gaap/2024
0001213900-25-040402 20241231 Gains Losses On Restructuring Of Debt 14759000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Increase Decrease In Operating Lease Liability -156000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Interest Paid Net 833000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Liabilities Current 1780000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Liabilities Noncurrent 3000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001213900-25-040402 20221231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Operating Income Loss -8638000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Operating Lease Right Of Use Asset 1200000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Payments To Acquire Property Plant And Equipment 836000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Prepaid Expense And Other Assets Current 213000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Property Plant And Equipment Net 9189000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Reclassification Of Warrants Liability To Equity USD 4 0001213900-25-040402
0001213900-25-040402 20241231 Research And Development Expense 5532000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Restricted Cash Current 140000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Revenues USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred At Point In Time;
0001213900-25-040402 20231231 Revenues USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred At Point In Time;
0001213900-25-040402 20241231 Revenues 658000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Revenues 496000.0000 USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred Over Time;
0001213900-25-040402 20211231 Stockholders Equity -2055000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Stockholders Equity -2007000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Stockholders Equity -1740000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Stockholders Equity 5627000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20230930 Stock Issued During Period Shares New Issues 28939.0000 shares 0 us-gaap/2024
0001213900-25-040402 20231231 Stock Issued During Period Shares New Issues 521310.0000 shares 0 us-gaap/2024 Related Party Transactions By Related Party= American Depositary Shares;
0001213900-25-040402 20231231 Stock Issued During Period Shares Restricted Stock Award Gross 8108400.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20241231 Stock Issued During Period Value Conversion Of Units 5627000.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024
0001213900-25-040402 20241231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Stock Issued During Period Value Stock Options Exercised 250000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Stock Issued During Period Value Stock Options Exercised 250000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20241231 Stock Issued During Period Value Stock Options Exercised 1441000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Stock Issued During Period Value Stock Options Exercised 1441000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Additional Paid In Capital 119506000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1602000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Depreciation And Amortization 1649000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -272000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Fair Value Adjustment Of Warrants USD 4 us-gaap/2024
0001213900-25-040402 20231231 Financial Expense Related To Loan From Others 401000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Gross Profit USD 4 us-gaap/2024
0001213900-25-040402 20231231 Gross Profit USD 4 us-gaap/2024
0001213900-25-040402 20241231 Increase Decrease In Accounts Receivable 83000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Liabilities Current 1806000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Net Cash Provided By Used In Investing Activities -12000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Net Income Loss 4796000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Operating Lease Liability Noncurrent 797000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Preferred Stock No Par Value USD 0 us-gaap/2024
0001213900-25-040402 20231231 Preferred Stock Shares Authorized 0.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Preferred Stock Shares Authorized 1000.0000 shares 0 us-gaap/2024
0001213900-25-040402 20221231 Proceeds From Warrant Exercises 5844000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Property Plant And Equipment Net 10825000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Reclassification Of Warrants Liability To Equity USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Research And Development Expense 5765000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Restricted Cash Current 131000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20211231 Stockholders Equity 982000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20211231 Stockholders Equity -110039000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Stock Issued During Period Shares Issuance And Exercise Of Warrantsin Shares 160000000.0000 shares 4 0001213900-25-040402 Equity Components= Common Stock;
0001213900-25-040402 20221231 Stock Issued During Period Shares New Issues 168104520.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Issued For Services 270000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Stock Issued During Period Value Issued For Services 270000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20241231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20221231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20231231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Warrants And Rights Outstanding 3000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1602000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Warrant Issued 1086000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Assets 17472000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20211231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 17517000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14215000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 5010000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -3302000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-040402 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-040402 20221231 Comprehensive Income Net Of Tax -5748000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Depreciation And Amortization 562000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Exercise Of Warrants Liability Into Shares 801000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20231231 Expense Of Inprocess Research And Development USD 4 0001213900-25-040402
0001213900-25-040402 20241231 Expense Of Inprocess Research And Development USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Financial Expense Related To Loan From Others -4113000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Increase Decrease In Accounts And Other Receivables -140000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Increase Decrease In Other Accounts Payable 157000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Liabilities And Stockholders Equity 13448000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Net Cash Provided By Used In Investing Activities -637000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Net Income Loss -5796000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20241231 Net Income Loss 4796000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Operating Lease Liability Current 396000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Other Comprehensive Income Loss Net Of Tax 48000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20241231 Other Loans Payable Long Term 260000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Payments To Acquire Property Plant And Equipment 637000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Preferred Stock Value USD 0 us-gaap/2024
0001213900-25-040402 20231231 Proceeds From Issuance Of Warrants 86000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Reclassifications Of Temporary To Permanent Equity 398000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Reclassifications Of Temporary To Permanent Equity 398000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Research And Development Expense 5210000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Restricted Cash 140000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Retained Earnings Accumulated Deficit -122335000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Revenues USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred Over Time;
0001213900-25-040402 20241231 Selling General And Administrative Expense 2526000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20211231 Shares Outstanding 739048544.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Stockholders Equity -1740000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Stockholders Equity -117539000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20240831 Stock Issued During Period Shares New Issues 1000.0000 shares 0 us-gaap/2024 Debt Instrument= E I B Loan;
0001213900-25-040402 20241231 Stock Issued During Period Shares Stock Options Exercised 1262800.0000 shares 4 us-gaap/2024
0001213900-25-040402 20241231 Stock Issued During Period Value Issuance Of Prefunded Shares 2000000.0000 USD 4 0001213900-25-040402 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20241231 Accounts Payable Trade Current 376000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Accounts Receivable Net Current 83000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 869000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 869000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2915000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Common Stock Shares Issued 3411983584.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -9000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Gains Losses On Restructuring Of Debt USD 4 us-gaap/2024
0001213900-25-040402 20241231 Interest Paid Net 143000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Liabilities Noncurrent 96000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001213900-25-040402 20221231 Net Cash Provided By Used In Financing Activities 6776000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Net Cash Provided By Used In Financing Activities 3441000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Net Income Loss -5796000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Nonoperating Income Expense -1325000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Operating Lease Liability Current 424000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Other Comprehensive Income Loss Net Of Tax 267000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20231231 Other Loans Payable Long Term 19368000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Preferred Stock No Par Value USD 0 us-gaap/2024
0001213900-25-040402 20231231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001213900-25-040402 20221231 Proceeds From Issuance Of Common Stock 932000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Reclassification Of Warrants Liability To Equity 398000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20231231 Reclassifications Of Temporary To Permanent Equity USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Restricted Cash 131000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Revenues USD 4 us-gaap/2024
0001213900-25-040402 20231231 Revenues USD 4 us-gaap/2024
0001213900-25-040402 20231231 Revenues USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred Over Time; Amount of $389 is related to one customer
0001213900-25-040402 20241231 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 952000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Selling General And Administrative Expense 5296000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Selling General And Administrative Expense 4505000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Shares Outstanding 1857169984.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20211231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20221231 Stockholders Equity -1760000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Stockholders Equity 123629000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20241231 Stock Issued During Period Value Conversion Of Units 5627000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Accounts Payable Other Current 849000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Accounts Receivable Net Current USD 0 us-gaap/2024
0001213900-25-040402 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -1740000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 682000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 682000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Assets Noncurrent 12025000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Assets Noncurrent 11057000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Common Stock No Par Value USD 0 us-gaap/2024
0001213900-25-040402 20221231 Cost Of Revenue USD 4 us-gaap/2024
0001213900-25-040402 20231231 Cost Of Revenue USD 4 us-gaap/2024
0001213900-25-040402 20221231 Earnings Per Share Basic 0.0100 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Earnings Per Share Basic USD 4 us-gaap/2024
0001213900-25-040402 20221231 Expense Of Inprocess Research And Development 209000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20241231 Gross Profit -580000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Accounts And Other Receivables 290000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Increase Decrease In Accounts Payable Trade -156000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Increase Decrease In Other Operating Assets -153000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Liabilities And Stockholders Equity 17472000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Loan Convert Into Preferred Shares 5627000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20241231 Operating Expenses 8058000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Operating Income Loss -9706000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 267000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Other Nonoperating Income USD 4 us-gaap/2024
0001213900-25-040402 20241231 Preferred Stock Shares Outstanding 1000.0000 shares 0 us-gaap/2024
0001213900-25-040402 20241231 Preferred Stock Value 5627000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Prepaid Expense And Other Assets Current 437000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Reclassifications Of Temporary To Permanent Equity USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20221231 Revenues USD 4 us-gaap/2024 Product Or Service= License;
0001213900-25-040402 20241231 Revenues 62000.0000 USD 4 us-gaap/2024 Timing Of Transfer Of Good Or Service= Transferred At Point In Time;
0001213900-25-040402 20221231 Right Of Use Asset Obtained In Exchange For Operating Lease Liability USD 4 us-gaap/2024
0001213900-25-040402 20221231 Share Based Compensation 1602000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Shares Outstanding 3411983584.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20211231 Stockholders Equity 113076000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Stockholders Equity -115835000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Stockholders Equity -4569000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20241231 Stock Issued During Period Shares Conversion Of Units 1000.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20221231 Stock Issued During Period Shares Share Based Compensation 7077720.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20221231 Stock Issued During Period Shares Stock Options Exercised 75060000.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20241231 Stock Issued During Period Shares Stock Options Exercised 1042620000.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Stock Issued During Period Value New Issues 1154000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20231231 Stock Issued During Period Value Restricted Stock Award Gross 635000.0000 USD 4 us-gaap/2024 Award Type= Restricted Stock Units R S U;
0001213900-25-040402 20241231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20221231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Value Stock Options Exercised USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Weighted Average Number Of Diluted Shares Outstanding 1562627495.0000 shares 4 us-gaap/2024
0001213900-25-040402 20241231 Accounts Payable Other Current 1006000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20241231 Assets 13448000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Cash And Cash Equivalents At Carrying Value 4870000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Cash And Cash Equivalents At Carrying Value 1964000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2095000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Common Stock Shares Authorized 40000000000.0000 shares 0 us-gaap/2024
0001213900-25-040402 20221231 Earnings Per Share Diluted 0.0100 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Earnings Per Share Diluted USD 4 us-gaap/2024
0001213900-25-040402 20221231 Exercise Of Warrants Liability Into Shares 250000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20241231 Financial Expense Related To Loan From Others 1278000.0000 USD 4 0001213900-25-040402
0001213900-25-040402 20231231 Net Cash Provided By Used In Operating Activities -9382000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20241231 Increase Decrease In Accounts And Other Receivables -224000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Operating Lease Liability -58000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Interest Paid Net 916000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Net Cash Provided By Used In Operating Activities -7265000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Nonoperating Income Expense 5265000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Operating Income Loss -11061000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Preferred Shares Redemption Amount 34000000.0000 USD 0 0001213900-25-040402
0001213900-25-040402 20240831 Preferred Stock Shares Issued 1000.0000 shares 0 us-gaap/2024 Class Of Stock= Preferred Stock;
0001213900-25-040402 20241231 Preferred Stock Shares Issued 1000.0000 shares 0 us-gaap/2024
0001213900-25-040402 20231231 Proceeds From Issuance Of Common Stock 139000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Proceeds From Warrant Exercises 1441000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Revenues USD 4 us-gaap/2024 Product Or Service= License;
0001213900-25-040402 20231231 Right Of Use Asset Obtained In Exchange For Operating Lease Liability USD 4 us-gaap/2024
0001213900-25-040402 20241231 Shares Outstanding 1000.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Stock Issued During Period Shares Issued For Services 115755600.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20240731 Stock Issued During Period Shares New Issues 1000.0000 shares 0 us-gaap/2024 Debt Instrument= E I B Loan;
0001213900-25-040402 20241231 Weighted Average Number Of Diluted Shares Outstanding 3225472266.0000 shares 4 us-gaap/2024
0001213900-25-040402 20231231 Liabilities Noncurrent 20261000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Accounts Payable Trade Current 535000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -1740000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Additional Paid In Capital 123629000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Adjustments To Additional Paid In Capital Warrant Issued USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20241231 Assets Current 2391000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Cash And Cash Equivalents At Carrying Value 14075000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20231231 Depreciation And Amortization 514000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Fair Value Adjustment Of Warrants -4140000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Fair Value Adjustment Of Warrants -93000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Increase Decrease In Accounts Payable Trade -150000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Increase Decrease In Operating Lease Liability -314000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Loan Convert Into Preferred Shares USD 4 0001213900-25-040402
0001213900-25-040402 20221231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-040402 20221231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Net Income Loss -6500000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Nonoperating Income Expense 3206000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Operating Expenses 11061000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Operating Expenses 9706000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Operating Lease Liability Noncurrent 1402000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 48000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Other Comprehensive Income Loss Net Of Tax 267000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20231231 Other Comprehensive Income Loss Net Of Tax USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001213900-25-040402 20231231 Other Nonoperating Income 9000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Payments Of Stock Issuance Costs 129000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Payments To Acquire Property Plant And Equipment 12000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Retained Earnings Accumulated Deficit -117539000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20241231 Revenues 100000.0000 USD 4 us-gaap/2024 Product Or Service= License;
0001213900-25-040402 20231231 Share Based Compensation 1139000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20241231 Share Based Compensation 682000.0000 USD 4 us-gaap/2024
0001213900-25-040402 20221231 Shares Outstanding 989290784.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20221231 Stockholders Equity 116082000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20221231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Stockholders Equity 119506000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-040402 20231231 Stockholders Equity -122335000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-040402 20241231 Stock Issued During Period Shares Restricted Stock Award Gross 63572800.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-040402 20231231 Warrants And Rights Outstanding 96000.0000 USD 0 us-gaap/2024
0001213900-25-040402 20221231 Weighted Average Number Of Diluted Shares Outstanding 754076407.0000 shares 4 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Other Nonoperating Income us-gaap/2024 0 0 monetary D C Other Nonoperating Income Amount of income related to nonoperating activities, classified as other.
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Increase Decrease In Accounts Payable Trade us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 0 0 monetary D D Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
Stock Issued During Period Value Conversion Of Units us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Units Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Expense Of Inprocess Research And Development 0001213900-25-040402 1 0 monetary D D Expense Of Inprocess Research And Development Amount of expense of in-process research and development.
Stock Issued During Period Shares Issuance And Exercise Of Warrantsin Shares 0001213900-25-040402 1 0 shares D Stock Issued During Period Shares Issuance And Exercise Of Warrantsin Shares Number of shares issued in issuance and exercise of warrants in shares.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Restricted Cash Current us-gaap/2024 0 0 monetary I D Restricted Cash, Current Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Increase Decrease In Accounts And Other Receivables us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts and Other Receivables The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Financial Expense Related To Loan From Others 0001213900-25-040402 1 0 monetary D D Financial Expense Related To Loan From Others Amount of financial expense related to loan from others.
Stock Issued During Period Value Issuance Of Prefunded Shares 0001213900-25-040402 1 0 monetary D C Stock Issued During Period Value Issuance Of Prefunded Shares Value of shares of stock issuance of prefunded shares
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Increase Decrease In Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Reclassifications Of Temporary To Permanent Equity us-gaap/2024 0 0 monetary D C Reclassifications of Temporary to Permanent Equity The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Preferred Shares Redemption Amount 0001213900-25-040402 1 0 monetary I D Preferred Shares Redemption Amount The amount of preferred shares redemption amount.
Payments Of Stock Issuance Costs us-gaap/2024 0 0 monetary D C Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security.
Accounts Payable Other Current us-gaap/2024 0 0 monetary I C Accounts Payable, Other, Current Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.
Accounts Payable Trade Current us-gaap/2024 0 0 monetary I C Accounts Payable, Trade, Current Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Warrants And Rights Outstanding us-gaap/2024 0 0 monetary I C Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
Loan Convert Into Preferred Shares 0001213900-25-040402 1 0 monetary D D Loan Convert Into Preferred Shares The amount of loan convert into preferred shares.
Exercise Of Warrants Liability Into Shares 0001213900-25-040402 1 0 monetary D D Exercise Of Warrants Liability Into Shares Amount of exercise of warrants liability into shares.
Common Stock No Par Value us-gaap/2024 0 0 perShare I Common Stock, No Par Value Face amount per share of no-par value common stock.
Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Restricted Cash us-gaap/2024 0 0 monetary I D Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Issuance Of Warrants us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Stock Issued During Period Shares Exercise Of Prefunded Warrant 0001213900-25-040402 1 0 shares D Stock Issued During Period Shares Exercise Of Prefunded Warrant Number of shares issued during the period as a exercise of prefunded warrant.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Assets Noncurrent us-gaap/2024 0 0 monetary I D Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Finance Costs Net us-gaap/2024 0 0 monetary I D Debt Issuance Costs, Net Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Stock Issued During Period Shares Conversion Of Units us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Units The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Loans Payable Long Term us-gaap/2024 0 0 monetary I C Other Loans Payable, Long-Term, Noncurrent Amount of long-term loans classified as other, payable after one year or the operating cycle, if longer.
Preferred Stock No Par Value us-gaap/2024 0 0 perShare I Preferred Stock, No Par Value Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Reclassification Of Warrants Liability To Equity 0001213900-25-040402 1 0 monetary D D Reclassification Of Warrants Liability To Equity Amount of reclassification of warrants liability to equity.
Gains Losses On Restructuring Of Debt us-gaap/2024 0 0 monetary D C Gains (Losses) on Restructuring of Debt For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.
Increase Decrease In Other Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Proceeds From Warrant Exercises us-gaap/2024 0 0 monetary D D Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Stock Issued During Period Shares Share Based Compensation us-gaap/2024 0 0 shares D Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001213900-25-040402 3 2 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001213900-25-040402 3 3 BS 0 H Restricted Cash Current us-gaap/2024 Restricted cash 0
0001213900-25-040402 3 4 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other receivables 0
0001213900-25-040402 3 5 BS 0 H Accounts Receivable Net Current us-gaap/2024 Trade receivables 0
0001213900-25-040402 3 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001213900-25-040402 3 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment, net 0
0001213900-25-040402 3 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets 0
0001213900-25-040402 3 10 BS 0 H Assets Noncurrent us-gaap/2024 Total non-current assets 0
0001213900-25-040402 3 11 BS 0 H Assets us-gaap/2024 Total assets 0
0001213900-25-040402 3 13 BS 0 H Accounts Payable Trade Current us-gaap/2024 Trade payables 0
0001213900-25-040402 3 14 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities 0
0001213900-25-040402 3 15 BS 0 H Accounts Payable Other Current us-gaap/2024 Other payables 0
0001213900-25-040402 3 16 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001213900-25-040402 3 18 BS 0 H Warrants And Rights Outstanding us-gaap/2024 Warrants liability 0
0001213900-25-040402 3 19 BS 0 H Other Loans Payable Long Term us-gaap/2024 Loan from others 0
0001213900-25-040402 3 20 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Non-current operating lease liabilities 0
0001213900-25-040402 3 21 BS 0 H Liabilities Noncurrent us-gaap/2024 Total non-current liabilities 0
0001213900-25-040402 3 22 BS 0 H Commitments And Contingencies us-gaap/2024 CONTINGENT LIABILITIES AND COMMITMENTS 0
0001213900-25-040402 3 24 BS 0 H Common Stock Value us-gaap/2024 Ordinary shares of no par value: Authorized: 40,000,000,000 shares at December 31, 2024 and 20,000,000,000 at December 31, 2023; Issued and outstanding 3,411,983,584 shares at December 31, 2024 and 1,857,169,984 shares at December 31, 2023 0
0001213900-25-040402 3 25 BS 0 H Preferred Stock Value us-gaap/2024 Preferred shares, no par value; Authorized: 1,000 shares at December 31, 2024 (redemption amount of $34,000) and 0 shares at December 31, 2023; Issued and outstanding: 1,000 shares at December 31, 2024 and 0 shares at December 31, 2023 0
0001213900-25-040402 3 26 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001213900-25-040402 3 27 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001213900-25-040402 3 28 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0001213900-25-040402 3 29 BS 0 H Stockholders Equity us-gaap/2024 Total shareholders equity (deficit) 0
0001213900-25-040402 3 30 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and shareholders equity (deficit) 0
0001213900-25-040402 4 1 BS 1 H Common Stock No Par Value us-gaap/2024 Ordinary shares of no par value (in Dollars per share) 0
0001213900-25-040402 4 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Ordinary shares, authorized 0
0001213900-25-040402 4 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Ordinary shares, issued 0
0001213900-25-040402 4 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Ordinary shares, outstanding 0
0001213900-25-040402 4 5 BS 1 H Preferred Stock No Par Value us-gaap/2024 Preferred shares, par value (in Dollars per share) 0
0001213900-25-040402 4 6 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred shares, authorized 0
0001213900-25-040402 4 7 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred shares, issued 0
0001213900-25-040402 4 8 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred shares, outstanding 0
0001213900-25-040402 4 9 BS 1 H Preferred Shares Redemption Amount 0001213900-25-040402 Preferred shares, redemption amount (in Dollars) 0
0001213900-25-040402 5 1 IS 0 H Revenues us-gaap/2024 Revenues 0
0001213900-25-040402 5 2 IS 0 H Cost Of Revenue us-gaap/2024 Cost of revenues 0
0001213900-25-040402 5 3 IS 0 H Gross Profit us-gaap/2024 Gross loss 1
0001213900-25-040402 5 4 IS 0 H Research And Development Expense us-gaap/2024 Research and development expenses, net 0
0001213900-25-040402 5 5 IS 0 H Selling General And Administrative Expense us-gaap/2024 Marketing, general and administrative expenses 0
0001213900-25-040402 5 6 IS 0 H Other Nonoperating Income us-gaap/2024 Other income 1
0001213900-25-040402 5 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001213900-25-040402 5 8 IS 0 H Operating Income Loss us-gaap/2024 Total operating loss 1
0001213900-25-040402 5 9 IS 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on troubled debt restructuring 1
0001213900-25-040402 5 10 IS 0 H Nonoperating Income Expense us-gaap/2024 Financial expenses (income) net, 1
0001213900-25-040402 5 11 IS 0 H Net Income Loss us-gaap/2024 Net loss (Income) 1
0001213900-25-040402 5 12 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss (Income) per ordinary share attributable to shareholders, basic (in Dollars per share) 0
0001213900-25-040402 5 13 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss (Income) per ordinary share attributable to shareholders, diluted (in Dollars per share) 0
0001213900-25-040402 5 14 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average number of shares used in computing net loss (income) per share attributable to ordinary shareholders, basic (in Shares) 0
0001213900-25-040402 5 15 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average number of shares used in computing net loss (income) per share attributable to ordinary shareholders, diluted (in Shares) 0
0001213900-25-040402 6 1 CI 0 H Net Income Loss us-gaap/2024 Net loss (income) 1
0001213900-25-040402 6 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustments 1
0001213900-25-040402 6 4 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Total comprehensive loss (income) 1
0001213900-25-040402 7 10 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-040402 7 11 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-040402 7 12 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of shares, net of issuance costs of $129 0
0001213900-25-040402 7 13 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of shares, net of issuance costs of $129 (in Shares) 0
0001213900-25-040402 7 14 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Exercise of warrants, net of issuance costs of $263 0
0001213900-25-040402 7 15 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Exercise of warrants, net of issuance costs of $263 (in Shares) 0
0001213900-25-040402 7 16 EQ 0 H Stock Issued During Period Shares Exercise Of Prefunded Warrant 0001213900-25-040402 Exercise of prefunded warrant (in Shares) 0
0001213900-25-040402 7 17 EQ 0 H Stock Issued During Period Value Conversion Of Units us-gaap/2024 Loan conversion into preferred shares 0
0001213900-25-040402 7 18 EQ 0 H Stock Issued During Period Shares Conversion Of Units us-gaap/2024 Loan conversion into preferred shares (in Shares) 0
0001213900-25-040402 7 19 EQ 0 H Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 Vested RSUs 0
0001213900-25-040402 7 20 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 Vested RSUs (in Shares) 0
0001213900-25-040402 7 21 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Issuance and exercise of warrants 0
0001213900-25-040402 7 22 EQ 0 H Stock Issued During Period Shares Issuance And Exercise Of Warrantsin Shares 0001213900-25-040402 Issuance and exercise of warrants (in Shares) 0
0001213900-25-040402 7 23 EQ 0 H Reclassifications Of Temporary To Permanent Equity us-gaap/2024 Reclassification of warrants liability to equity 0
0001213900-25-040402 7 24 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation 0
0001213900-25-040402 7 25 EQ 0 H Stock Issued During Period Shares Share Based Compensation us-gaap/2024 Share-based compensation (in Shares) 0
0001213900-25-040402 7 26 EQ 0 H Stock Issued During Period Value Issuance Of Prefunded Shares 0001213900-25-040402 Issuance of prefunded warrants 0
0001213900-25-040402 7 27 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Shares issued for services 0
0001213900-25-040402 7 28 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Shares issued for services (in Shares) 0
0001213900-25-040402 7 29 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income 0
0001213900-25-040402 7 30 EQ 0 H Net Income Loss us-gaap/2024 Net Income (loss) 0
0001213900-25-040402 7 31 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-040402 7 32 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-040402 8 1 EQ 1 H Payments Of Stock Issuance Costs us-gaap/2024 Issuance of shares, net of issuance costs 0
0001213900-25-040402 8 2 EQ 1 H Proceeds From Issuance Of Warrants us-gaap/2024 Issuance of warrants and shares, net of issuance costs 0
0001213900-25-040402 8 3 EQ 1 H Deferred Finance Costs Net us-gaap/2024 Exercise of warrants, net of issuance costs 0
0001213900-25-040402 9 2 CF 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001213900-25-040402 9 4 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation of property, plant and equipment 0
0001213900-25-040402 9 5 CF 0 H Expense Of Inprocess Research And Development 0001213900-25-040402 Expense of in-process research and development 0
0001213900-25-040402 9 6 CF 0 H Financial Expense Related To Loan From Others 0001213900-25-040402 Financial income (expense) related to loan from others 0
0001213900-25-040402 9 7 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Revaluation of warrants 0
0001213900-25-040402 9 8 CF 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on troubled debt restructuring 1
0001213900-25-040402 9 9 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0001213900-25-040402 9 10 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Decrease (increase) in trade receivables 1
0001213900-25-040402 9 11 CF 0 H Increase Decrease In Accounts And Other Receivables us-gaap/2024 Decrease (increase) in other receivables 1
0001213900-25-040402 9 12 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Changes in operating lease right-of-use assets 1
0001213900-25-040402 9 13 CF 0 H Increase Decrease In Accounts Payable Trade us-gaap/2024 Increase (decrease) in trade payables 0
0001213900-25-040402 9 14 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Changes in operating lease liabilities 0
0001213900-25-040402 9 15 CF 0 H Increase Decrease In Other Accounts Payable us-gaap/2024 Increase (decrease) in other payables 0
0001213900-25-040402 9 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001213900-25-040402 9 18 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property, plant and equipment 1
0001213900-25-040402 9 19 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001213900-25-040402 9 21 CF 0 H Proceeds From Warrant Exercises us-gaap/2024 Proceed from exercise of warrants, net 0
0001213900-25-040402 9 22 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of shares, net 0
0001213900-25-040402 9 23 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001213900-25-040402 9 24 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on cash, cash equivalents and restricted cash 0
0001213900-25-040402 9 25 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Increase (decrease) in cash, cash equivalents and restricted cash 0
0001213900-25-040402 9 26 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at beginning of year 0
0001213900-25-040402 9 27 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at end of year 0
0001213900-25-040402 9 29 CF 0 H Interest Paid Net us-gaap/2024 Interest 0
0001213900-25-040402 9 31 CF 0 H Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 Recognition of right-of-use assets and lease liabilities upon exercise of lease extension option 0
0001213900-25-040402 9 32 CF 0 H Reclassification Of Warrants Liability To Equity 0001213900-25-040402 Reclassification of warrants liability to equity 0
0001213900-25-040402 9 33 CF 0 H Loan Convert Into Preferred Shares 0001213900-25-040402 Loan convert into preferred shares 0
0001213900-25-040402 9 34 CF 0 H Exercise Of Warrants Liability Into Shares 0001213900-25-040402 Exercise of warrants liability into shares 0
0001213900-25-040402 9 36 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001213900-25-040402 9 37 CF 0 H Restricted Cash us-gaap/2024 Restricted cash 0
0001213900-25-040402 9 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.